United Kingdom · Biopharma startup
United Kingdom · Asklepios BioPharmaceutical
Asklepios BioPharmaceutical is a biotechnology company developing adeno-associated virus (AAV) gene therapies for genetic disorders.
Funding reportedLast round: Grant
Follow Asklepios BioPharmaceutical and see its new rounds in your feed.Start following
What company datasets say Asklepios BioPharmaceutical raised
Funding, as reported
Reported in all241.8Min the source's currency
Rounds4
Last roundGrant
Last round dateSept 2020
Investors listed4
On a portfolio page
Investors who name them
Each firm lists Asklepios BioPharmaceutical on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biopharma in United Kingdom
Startups like it
Is this your company?
Add your raise, your deck and your story, and put Asklepios BioPharmaceutical in front of investors. Or tell us what we have wrong.